Concepedia

Nathaniel Washburn

NW

Statistics

Publications

10

Citations

804

H-Index

10

Active since

2009

Affiliations

Momenta Pharmaceuticals (United States)(Current)

Harvard University

Massachusetts General Hospital

Friedrich-Alexander-Universität Erlangen-Nürnberg

Nathaniel Washburn is an author at Momenta Pharmaceuticals (United States) specializing in life sciences, immunology, and immunoglobulin function.

ORCID

Publications per year

2009–2020

10

Publications

10

Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity

Nathaniel Washburn, Inessa Schwab, Daniel Ortiz et al. · Proceedings of the National Academy of Sciences · 2015 · 226 citations · Full text

, , +17

Sialylation of immunoglobulin E is a determinant of allergic pathogenicity

Kai-Ting Shade, Michelle E. Conroy, Nathaniel Washburn et al. · Nature · 2020 · 167 citations · Full text

, , +14

A single glycan on IgE is indispensable for initiation of anaphylaxis

Kai-Ting Shade, Barbara Platzer, Nathaniel Washburn et al. · The Journal of Experimental Medicine · 2015 · 150 citations · Full text

, , +17

Profiling the Glycoforms of the Intact α Subunit of Recombinant Human Chorionic Gonadotropin by High-Resolution Capillary Electrophoresis−Mass Spectrometry

Dipak Thakur, Tomáš Rejtar, Barry L. Karger et al. · Analytical Chemistry · 2009 · 70 citations

, , +17

Elucidating the interplay between IgG-Fc valency and FcγR activation for the design of immune complex inhibitors

Daniel Ortiz, Jonathan C. Lansing, Laura I. Rutitzky et al. · Science Translational Medicine · 2016 · 66 citations

, , +14

1–5 of 10